Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas

Journal of Cutaneous Pathology

Volumn 35, Issue 1, 2008, Pages 40-45

  Heyl, Jennifer ^a   Mehregan, Darius ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pinkus Dermatopathology Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; MONOCLONAL ANTIBODY;

ADENOMA; ADULT; AGED; ANTIBODY LABELING; ARTICLE; BASAL CELL CARCINOMA; CARCINOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EPITHELIUM TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN EXPRESSION; SEBACEOUS GLAND TUMOR;

ADENOCARCINOMA, SEBACEOUS; ADENOMA; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; KERATIN-19; MIDDLE AGED; SEBACEOUS GLAND NEOPLASMS; SEBACEOUS GLANDS; TUMOR MARKERS, BIOLOGICAL;

EID: 37249054580     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00777.x     Document Type: Article

References (19)

1. Elder D, Elenitsas R, Ioffreda M, et al. Sebaceous adenoma and sebaceous epithelioma (sebaceoma). In Elder D, Elenitsas R, Ioffreda M, Johnson BL, eds. Synopsis and atlas of Lever's histopathology of the skin, 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1999 304.
2. Troy JL, Ackerman AB. Sebaceoma. A distinctive benign neoplasm of adnexal epithelium differentiating toward sebaceous cells. Am J Dermatopathol 1984 6: 7.
3. Misago N, Narisawa Y. Rippled-pattern sebaceoma. Am J Dermatopathol 2001 23: 437.
4. Rutten A, Burgdorf W, Hugel H, et al. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study. Am J Dermatopathol 1999 21: 405.
5. Misago N, Narisawa Y. Sebaceous neoplasms in Muir-Torre syndrome. Am J Dermatopathol 2000 22: 155.
6. Wick MR, Goellner JR, Wolfe JT III., Su WP. Adnexal carcinomas of the skin. II. Extraocular sebaceous carcinomas. Cancer 1985 56: 1163.
7. Kohler S, Rouse RV, Smoller BR. The differential diagnosis of pagetoid cells in the epidermis. Mod Pathol 1998 11: 79.
8. Nguyen GK, Mielke BW. Extraocular sebaceous carcinoma with intraepidermal (pagetoid) spread. Am J Dermatopathol 1987 9: 364.
9. Wong CSM, Strange RC, Lear JT. Basal cell carcinoma. BMJ 2003 327: 794.
10. Misago N, Suse T, Uemura T, Narisawa Y. Basal cell carcinoma with sebaceous differentiation. Am J Dermatopathol 2004 4: 298.
11. Michel M, Torok N, Godbout MJ, et al. Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage. J Cell Sci 1996 109: 1017.
12. Bader BL, Jahn L, Franke WW. Low level expression of cytokeratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived there from, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. Eur J Cell Biol 1988 47: 300.
13. Dumez A, Verslype C, Nevens F, et al. The clinicopathologic and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006 49: 138.
14. Papini S, Rosellini A, Nardi M, Giannarini C, Revoltella R. Selective growth and expansion of human corneal epithelial basal stem cells in a three-dimensional-organ culture. Differentiation 2005 73: 61.
15. Stoll C, Stollenwerk C, Riediger D, Mittermaye C, Alfer J. Cytokeratin expression patterns for distinction of odontogenic keratocysts from dentigerous and radicular cysts. J Oral Pathol Med 2005 34: 558.
16. Figen A, Cuyan D, Penbe C, Nukhet T. Expression of cytokeratin subtypes in intraepidermal malignancies: a guide for differentiation. J Cutan Pathol 2000 33: 531.
17. Metze D, Soyer H, Zelger B, et al. Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands. J Am Acad Dermatol 1996 34: 735.
18. Sinard JH. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma. Arch Ophthalmol 1999 117: 776.
19. Bayer-Garner IB, Givens V, Smoller B. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol 1999 21: 426.